This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Company Profile For Alere Analytics

Alere Analytics, formerly DiagnosisOne, provides the healthcare industry with unparalleled analytics and clinical decision support tools based on a single platform. The Company leverages the world's largest library of evidence-based medical knowledge and integrates seamlessly with existing hospital and laboratory information systems. It delivers intelligent and actionable information that ensures improved patient care, fewer errors and better clinical outcomes. Our solutions are built on the most up-to-date methods of data interoperability including HL7 v3.0/2.X, CCD and CDA standards. Alere Analytics’ customers include hospitals, healthcare providers, payers, EHR companies, systems integrators and government entities. Based in Lowell, Mass., Alere Analytics was formed as DiagnosisOne in 2003 by a team of physicians and healthcare IT professionals. In July 2012, DiagnosisOne joined Alere, a leading provider of near-patient diagnostics and health information solutions, and is now conducting business as Alere Analytics. For more information about the Company and its solutions, visit www.alereanalytics.com.

Company:

  Alere Analytics
 

Headquarters Address:

900 Chelmsford Street

Tower 3, 7th Floor
Lowell, MA 01851
 

Main Telephone:

9788564600
 

Website:

www.alereanalytics.com

 

Ticker:

ALR(NYSE)
 

Type of Organization:

Public
 

Industry:

Software
 

Key Executives:

CEO: Mansoor Khan

CMO: Fauzia Khan

 

Public Relations

 

Contact:

Lisa Rivero

Phone:

9788564524

Email:

lisa.rivero@alere.com





Copyright Business Wire 2010

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs